These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26479787)

  • 1. Translational Research and Plasma Proteomic in Cancer.
    Santini AC; Giovane G; Auletta A; Di Carlo A; Fiorelli A; Cito L; Astarita C; Giordano A; Alfano R; Feola A; Di Domenico M
    J Cell Biochem; 2016 Apr; 117(4):828-35. PubMed ID: 26479787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer.
    Yang Y; Pospisil P; Iyer LK; Adelstein SJ; Kassis AI
    PLoS One; 2008; 3(11):e3661. PubMed ID: 18987750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic strategies for the characterization and the early detection of lung cancer.
    Massion PP; Caprioli RM
    J Thorac Oncol; 2006 Nov; 1(9):1027-39. PubMed ID: 17409991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
    Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
    J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research progress in applying proteomics technology to explore early diagnosis biomarkers of breast cancer, lung cancer and ovarian cancer.
    Luo L; Dong LY; Yan QG; Cao SJ; Wen XT; Huang Y; Huang XB; Wu R; Ma XP
    Asian Pac J Cancer Prev; 2014; 15(20):8529-38. PubMed ID: 25374164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical proteomics and biomarker discovery.
    Johann DJ; McGuigan MD; Patel AR; Tomov S; Ross S; Conrads TP; Veenstra TD; Fishman DA; Whiteley GR; Petricoin EF; Liotta LA
    Ann N Y Acad Sci; 2004 Jun; 1022():295-305. PubMed ID: 15251975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
    Ma H; Chen G; Guo M
    Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncoproteomics: Trials and tribulations.
    Zhou L; Li Q; Wang J; Huang C; Nice EC
    Proteomics Clin Appl; 2016 Apr; 10(4):516-31. PubMed ID: 26518147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic studies of early-stage and advanced ovarian cancer patients.
    Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
    Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics of ovarian cancer: functional insights and clinical applications.
    Elzek MA; Rodland KD
    Cancer Metastasis Rev; 2015 Mar; 34(1):83-96. PubMed ID: 25736266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K-ras mutations in circulating DNA from pancreatic and lung cancers: bridging methodology for a common validation of the molecular diagnosis value.
    Magistrelli P; Neri M; Granone P; Cesario A; Paleari L; Russo P
    Pancreas; 2008 Jul; 37(1):101-2. PubMed ID: 18580451
    [No Abstract]   [Full Text] [Related]  

  • 12. Proteomic applications for the early detection of cancer.
    Wulfkuhle JD; Liotta LA; Petricoin EF
    Nat Rev Cancer; 2003 Apr; 3(4):267-75. PubMed ID: 12671665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optomechanical devices for deep plasma cancer proteomics.
    Kosaka PM; Calleja M; Tamayo J
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):26-38. PubMed ID: 28867489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution serum proteomic features for ovarian cancer detection.
    Conrads TP; Fusaro VA; Ross S; Johann D; Rajapakse V; Hitt BA; Steinberg SM; Kohn EC; Fishman DA; Whitely G; Barrett JC; Liotta LA; Petricoin EF; Veenstra TD
    Endocr Relat Cancer; 2004 Jun; 11(2):163-78. PubMed ID: 15163296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer.
    Kong F; Nicole White C; Xiao X; Feng Y; Xu C; He D; Zhang Z; Yu Y
    Gynecol Oncol; 2006 Feb; 100(2):247-53. PubMed ID: 16229881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics in prostate cancer biomarker discovery.
    Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
    Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic Approaches for Biomarker Panels in Cancer.
    Tanase C; Albulescu R; Neagu M
    J Immunoassay Immunochem; 2016; 37(1):1-15. PubMed ID: 26565430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic profiling of pancreatic cancer for biomarker discovery.
    Chen R; Pan S; Brentnall TA; Aebersold R
    Mol Cell Proteomics; 2005 Apr; 4(4):523-33. PubMed ID: 15684406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker discovery in ovarian cancer.
    Tung CS; Wong KK; Mok SC
    Womens Health (Lond); 2008 Jan; 4():27-40. PubMed ID: 19072449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive modeling in proteomics-based disease detection.
    Pham TD
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():3308-11. PubMed ID: 18002703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.